DeCure's autonomous Neuro AI scientist is researching a drug-repurposing hypothesis for sensory peripheral neuropathy — screening already-approved drugs against its 3-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSensory peripheral neuropathy maps to a 3-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for sensory peripheral neuropathy is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
protoporphyrinogen oxidase (PPOX) — PPOX is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet trifluoromethyldrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 3NKS · 1.9 Å · ligand 5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID (ACJ). Experimental structure, not a prediction.
What the evidence adds up to
A 2009 review describes neuropathic pain as a syndrome distinct from other pain types, arising after peripheral nerve injury and involving peripheral sensitisation in primary afferents and central sensitisation in central neurons. The authors state that future treatment is likely to move toward agents that more specifically attack the pain-generating mechanisms, but no specific drug is named or tested in that abstract. A 2012 chapter notes that inherited peripheral neuropathies with nociception defects have over 30 causative genes identified, but it does not report any clinical trial results or drug interventions.
A 2019 text describes a commercial program called The Neuropathy Solution, authored by Randall Labrum, which claims to offer natural, non-prescription relief for peripheral neuropathy from various causes. The program is presented as an ebook with step-by-step procedures, but no data from any controlled study, no patient numbers, no response rates, and no survival figures are provided. The text makes unsupported claims of reversing nerve damage and providing long-term relief without evidence.
No abstract in this set reports a clinical trial, a measurable outcome, or a drug tested for sensory peripheral neuropathy. The 2009 review offers a mechanistic framework but no efficacy data. The 2012 chapter catalogues genetic causes without treatment results. The 2019 commercial product provides no verifiable evidence. What is missing is any randomised controlled trial, any quantitative measure of symptom improvement, any patient stratification by neuropathy subtype or cause, and any funding for rigorous, independent clinical investigation.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
European Journal of Pain Supplements · 2009 · 23 citations
Neuropathic pain: Peripheral and central mechanisms
AbstractAbstract Neuropathic pain refers to a specific pain syndrome characterized by pain and sensory abnormalities in body parts that have lost their normal peripheral innervation or sensory representation. They are to be distinguished from other types of pain because of differences in the underlying pathophysiology and treatment. Following a peripheral nerve injury, a cascade of events occurs in primary afferents causing peripheral sensitization. Central sensitization, which is increased responsiveness in central neurons, is usually the result of an increased barrage from the periphery, but may also occur independent of such peripheral input. Again, a series of molecular changes contribute to this central sensitization. These peripheral and central sensitization phenomena in neuropathic pain represent the pathophysiological reason for the beneficial effect of antihyperalgesic treatment in this type of pain. In future, such treatment is likely to be replaced by agents that in a more specific ways attack the pain‐generating mechanisms.
Oxford University Press eBooks · 2012 · 0 citations
Insensitivity to Pain: Lessons from Recent Genetics Advances
AbstractAbstract Inherited peripheral neuropathies are clinically and genetically heterogeneous with over 30 causative genes associated to these disorders. The present chapter will not discuss all of these neuropathies; it will address only those that have been associated primarily with nociception defects and relative degrees of autonomic dysfunction for which a causative gene has been identified. Nociception, the ability to feel pain following the stimulation of a sensory receptor, is physiologically a four-step process: transduction, transmission, modulation, and perception.
eScholarship (California Digital Library) · 2019 · 0 citations · open access
The Neuropathy Solution Program
AbstractNeuropathy Solution is a product that is designed for anyone who suffers from nerve pain, whether it is caused by diabetes, disease, chemotherapy, alcohol problems, hypertension or the aging process. Neuropathy can be a very uncomfortable and painful problem and its symptoms include tingling, numbness, stabbing pains, burning sensations and much more. It is an issue that affects your peripheral nervous system, which is the important part of your nervous system that sends information from your brain and spinal cord to the rest of your body. The Neuropathy Solution program offers you a natural way to fight against neuropathy without the use of prescription drugs. This is advantageous because you are not at risk of side effects. You will be able to cure your nerve pain without ever having to leave the comfort of your own home by following natural procedures. The steps to doing this are all outlined in an easy to follow way within the ebook The Neuropathy Solution, which is available to download online.The author of this program is a man called Randall Labrum, who suffered from peripheral neuropathy for many years. He worked hard to research the issue and he came up with this solution after studying for more than 35 years. The program that he has developed is a very efficient and effective solution to neuropathy pain and it promises long term relief. He knows what it feels like to suffer from neuropathy pain, which is why he worked so hard to put together this program and make sure that everyone could benefit from these very effective solutions.The Neuropathy Solution is a step by step treatment program that will provide you relief from your neuropathy pain. It is divided into several different sections that examine certain aspects of neuropathy. It will go into a discussion about diabetes and its relationship to peripheral neuropathy, as well as how the aging process leads to degeneration of your sensory nerves which will cause you nerve pain. It will explain to you what you can do to counteract this. The book also focuses on ways that you can revitalise the tissues of the body that have been irritated and damaged and how you can reverse the damage done to your nerve endings. You’ll also learn a lot of ways that you can improve your circulatory well being and overturn the effects of neuropathy. You’ll discover a lot about how your nerves work and why they start to malfunction and send these pain and tingling messages to your brain.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
